Moleculin Biotech, Inc. (MBRX) › Net IncomeMoleculin Biotech, Inc. (MBRX) — Net IncomeAnnual figures by fiscal year, from SEC filings.2016: -$3.93M2017: -$9.80M2018: -$11.88M2019: -$13.21M2020: -$17.36M2021: -$15.89M2022: -$29.02M2023: -$29.77M2024: -$26.05M2025: -$33.56M-$33.56M2016Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$33.56M-28.8%2024-$26.05M+12.5%2023-$29.77M-2.6%2022-$29.02M-82.6%2021-$15.89M+8.4%2020-$17.36M-31.4%2019-$13.21M-11.2%2018-$11.88M-21.1%2017-$9.80M-149.7%2016-$3.93M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share